SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-22-008239
Filing Date
2022-04-04
Accepted
2022-04-04 16:03:17
Documents
8
Period of Report
2022-04-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A esperion-2021proxystatement.htm PRE 14A 1242950
2 blookersigv2.jpg GRAPHIC 5422
3 espe_rmxrgbxfcxpos002.jpg GRAPHIC 44145
4 proxycard1back.jpg GRAPHIC 131464
5 proxycard1front.jpg GRAPHIC 89094
6 proxycard2back.jpg GRAPHIC 86718
7 proxycard2front.jpg GRAPHIC 102522
8 sheldonsignature.jpg GRAPHIC 20271
  Complete submission text file 0001628280-22-008239.txt   1881542
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35986 | Film No.: 22802040
SIC: 2834 Pharmaceutical Preparations